483 Octapharma Plasma Feb 2022

483 Octapharma Plasma Feb 2022

Matthew Gretkierewicz FDA, Jennifer Kemp FDA$119.00 - Available Now

FDA investigators audited the Octapharma Plasma - Saint Clair Shores, MI, United States facility and issued inspectional observations (via FDA 483) on 14 Feb 2022.

Product details

  • Category: Biologics
  • Inspection end: 14 Feb 2022
  • Location: Saint Clair Shores, United States
  • FEI: 3017830243
Add To Cart